Table 5.
Histopathological margin assessment after targeted re-excisions.
| a on specimen level | |||||||
|---|---|---|---|---|---|---|---|
| medial | lateral | cranial | caudal | frontal | dorsal | total | |
| R0 | 45 | 43 | 44 | 44 | 42 | 44 | 261 (87.0%) |
| R1 | 4 (3)a | 6 (4) | 5 (1) | 5 (4) | 8 (6) | 7 (5) | 35 (11.6%) |
| Rx | 1 (0) | 1 (1) | 1 (1) | 1 (1) | 0 (0) | 0 (0) | 4 (1.3%) |
|
b on specimen level, divided according to histological subtypes | ||||||
|---|---|---|---|---|---|---|
| NST | ILC | NST + ILC | DCIS | Other | total | |
| R0 | 190 | 21 | 10 | 30 | 10 | 261 (87.0%) |
| R1 | 10 | 1 | 0 | 23 | 1 | 35 (11.6%) |
| Rx | 1 | 0 | 0 | 3 | 0 | 4 (1.3%) |
|
c on case level | |
|---|---|
| Number of patientsb | |
| R0 | 31 (62) |
| R1 | 17 (34) |
| Rx | 2 (4) |
a
The number of in-situ carcinoma is given in parentheses.
b
Values are absolute frequencies. Relative frequencies are given as percentages in parentheses. Percentages are rounded.